Electroacupuncture Ameliorates Neuronal Injury by NLRP3/ASC/Caspase-1 Mediated Pyroptosis in Cerebral Ischemia-Reperfusion. 2024

Bin Tang, and Yan Li, and Xifa Xu, and Guangzhong Du, and Huanyuan Wang
Department of Acupuncture-Moxibustion and Tuina, Qilu Hospital of Shandong University, Shandong University, No. 107 Wenhuaxi Road, Lixia District, Jinan, 250012, People's Republic of China.

NLRP3/ASC/Caspase-1 mediated pyroptosis is one of the important causes of cerebral ischemia-reperfusion (I/R) injury. Electroacupuncture (EA) is widely used in clinical treatment of ischemic stroke. However, mechanism of EA on ischemic stroke remains unclear. Therefore, on basis of a previous work, this study used middle cerebral artery occlusion (MCAO) 2 h and then reperfusion 7 days in rats to simulate brain I/R process. EA with Bahui (GV20) and Zusanli (ST36) and VX-765 (a specific inhibitor of Caspase-1) was performed. In this study, we found that EA improved cerebral infarct size and neuronal damage, including ultrastructural injury, and ameliorated nitro/oxidative stress in cerebral I/R. Additionally, EA treatment significantly decreased ASC, Caspase-1, GSDMD, and IL-1β expression and VX-765 treatment significantly decreased NLRP3, Caspase-1, and IL-1β expression. This proved that EA can regulate NLRP3/ASC/Caspase-1 mediated pyroptosis, improve neuronal injury during cerebral I/R, and provide basic experimental data for clinical treatment.

UI MeSH Term Description Entries

Related Publications

Bin Tang, and Yan Li, and Xifa Xu, and Guangzhong Du, and Huanyuan Wang
October 2019, Nitric oxide : biology and chemistry,
Bin Tang, and Yan Li, and Xifa Xu, and Guangzhong Du, and Huanyuan Wang
January 2022, Frontiers in molecular neuroscience,
Bin Tang, and Yan Li, and Xifa Xu, and Guangzhong Du, and Huanyuan Wang
April 2023, Antioxidants (Basel, Switzerland),
Bin Tang, and Yan Li, and Xifa Xu, and Guangzhong Du, and Huanyuan Wang
January 2024, BioFactors (Oxford, England),
Bin Tang, and Yan Li, and Xifa Xu, and Guangzhong Du, and Huanyuan Wang
January 2025, Frontiers in pharmacology,
Bin Tang, and Yan Li, and Xifa Xu, and Guangzhong Du, and Huanyuan Wang
November 2019, Journal of physiology and biochemistry,
Bin Tang, and Yan Li, and Xifa Xu, and Guangzhong Du, and Huanyuan Wang
November 2020, Journal of neuroinflammation,
Bin Tang, and Yan Li, and Xifa Xu, and Guangzhong Du, and Huanyuan Wang
January 2022, Mediators of inflammation,
Bin Tang, and Yan Li, and Xifa Xu, and Guangzhong Du, and Huanyuan Wang
September 2023, DNA and cell biology,
Copied contents to your clipboard!